General Practitioners

This page lists 28 references in the Main Healthy Skepticism Library relevant to General Practitioners / Family Physicians.

Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.


HSL6964
Helbling J, Ajdacic-gross V, Lauber C, Weyermann R, Burns T, Rossler W.
Attitudes to antipsychotic drugs and their side effects: a comparison between general practitioners and the general population.
BMC Psychiatry 2006 Oct 18;6(1):42

HSL6808
Wong IC, Basra N, Yeung VW, Cope J.
Supply problems of unlicensed and off-label medicines after discharge.
Arch Dis Child 2006 Aug 01;91(8):686-8
http://adc.bmjjournals.com/cgi/content/full/91/8/686

HSL4370
Hall KB, Tett SE, Nissen LM.
Perceptions of the Influence of Prescription Medicine Samples on Prescribing by Family Physicians.
Med Care 2006 Apr 1;44(4):383-387
Link to source with long URL

HSL5346
Windmeijer F, de Laat E, Douven R, Mot E.
Pharmaceutical promotion and GP prescription behaviour.
Health Econ 2006 Jan;15(1):5-18
http://www3.interscience.wiley.com/cgi-bin/abstract/110504860/ABSTRACT

HSL5862
Chase J.
Physicians on pharma
Med Mark Media 2005 Dec 1;40:62-63

HSL6412
Toop L, Richards D, Dowell T.
Response to Maubach and Hoek's paper on GP attitudes to DTCA
N Z Med J. 2005 Jun 24;118(1217):U1543

HSL2482
Doucette WR, Andersen TN.
Practitioner activities in patient education and drug therapy monitoring for community dwelling elderly patients.
Patient Educ Couns 2005 May;57(2):204-10
Link to source with long URL

HSL2715
Muijrers P, Grol R., Sijbrandij J, Janknegt R., Knottnerus J
Differences in prescribing between general practitioners.
Unpublished 2005
Nil

HSL5844
Muijrers PE, Janknegt R, Sijbrandij J, Grol RP, Knottnerus JA.
Prescribing indicators. Development and validation of guideline-based prescribing indicators as an instrument to measure the variation in the prescribing behaviour of general practitioners.
Eur J Clin Pharmacol 2004 Dec 01;60(10):739-46
Link to source with long URL

HSL2719
Prosser H, Walley T.
New drug uptake: qualitative comparison of high and low prescribing GPs' attitudes and approach.
Fam Pract 2003 Oct;20(5):583-91
http://fampra.oxfordjournals.org/cgi/content/full/20/5/583

HSL6414
Toop L, Richards D, Dowell T.
The leadership role of general practice in public health: advocating a ban of direct-to-consumer advertising of prescription drugs in New Zealand.'Possums in the headlights?'.
Br J Gen Pract. 2003 Apr 1;53(489):342-5

HSL2441
Prosser H, Almond S, Walley T.
Influences on GPs' decision to prescribe new drugs-the importance of who says what.
Fam Pract 2003 Feb;20(1):61-8
http://fampra.oxfordjournals.org/cgi/content/full/20/1/61

HSL2684
Sheldon T.
Dutch GPs call for ban on Novartis products.
BMJ 2002 Aug 17;325(7360):355
http://bmj.bmjjournals.com/cgi/content/full/325/7360/355

HSL2296
Quinn RJ, O'Neill C.
Attitudes of general practitioners to their interactions with pharmaceutical companies: a qualitative study.
Ir Med J 2002 Jul-Aug;95(7):199-202
Link to source with long URL

HSL2167
Marcoux H, Lamontagne C, Cayer S, Desrochers A, Gauthier D.
[The development of ethics. Identifying what training in medical ethics is needed by family physicians]
Can Fam Physician 2001 Jun;47:1208-15

HSL2176
Damur C, Steurer J.
[Do physicians interpret therapy outcome differently than students?]
Schweiz Med Wochenschr 2000 Feb 12;130(6):171-6

HSL2438
Robinson P, Heywood P.
What do GPs need to know? The use of knowledge in general practice consultations.
Br J Gen Pract 2000 Jan;50(450):56-9
Link to source with long URL

HSL2158
Jackson C, Mcguire T, Dommers E, Nyst P.
A GP prescribing educational intervention involving a medication panel.
Aust Fam Physician 1999 Nov;28(11):1191-5

HSL2186
Kelly MH, Murray TS.
Motivation of general practitioners attending postgraduate education.
Br J Gen Pract 1996 Jun;46(407):353-6

HSL5700
Marley J, Mant A.
Post marketing surveillance. Traps for the unwary.
Aust Fam Physician 1993 Jun 01;22(6):1009-11,

HSL2192
Hayes TM, Allery LA, Harding KG, Owen PA.
Continuing education for general practice and the role of the pharmaceutical industry.
Br J Gen Pract 1990 Dec;40(341):510-2

HSL5826
Borgiel AE, Dunn EV, Lamont CT, MacDonald PJ, Evensen MK, Bass MJ, Spasoff RA, Williams JI.
Recruiting family physicians as participants in research.
Fam Pract 1989 Sep 01;6(3):168-72

HSL4032
Pitt L, Nel D.
Pharmaceutical promotion tools—their relative importance
European Journal of Marketing 1988;22:7-14

HSL3564
Kushner D.
Two-thirds of RPh's & MD's object to makers' promotion of Rx drugs to the public
American Druggist 1982 Oct;186(1):14, 16, 21-22

HSL3481
Strickland-Hodge B, Jeqson MH.
Usage of information sources by general practitioners.
J R Soc Med 1980 Dec;73(12):857-62

HSL3464
Gambrill J, Bridges-Webb C.
Use of sources of therapeutic and prescribing information by general practitioners.
Aust Fam Physician 1980 Jul;9(7):482-4

HSL693
Murray-Lyon N.
Communication in medicine: a study of how family doctors obtain information on recent advances in the treatment of rheumatic diseases.
Med Educ 1977 Mar;11(2):92-102
Nil

HSL3255
Gould D.
Can we handle modern drugs?
New Scientist 1974 May 23;62(899):460-1